Actiq Off-Label Marketing Suit Preempted, Pa. Panel Affirms
A Pennsylvania appeals court has refused to upend a trial judge's decision that federal law preempts claims that improper marketing of the Cephalon Inc. opiate painkiller "lollipop" Actiq led a plaintiff...To view the full article, register now.
Already a subscriber? Click here to view full article